GH Research GHRS
NASDAQ GHRS
$28.01 +0.09 (+0.32%)
As of: Sep 4, 2026 · 2:31 PM EDT

GH Research (GHRS) Other Non Operating Income (2020 - 2026)

GH Research (GHRS) posted quarterly Other Non Operating Income of $140000.0 for Q4 2025, down 93.6% year-over-year from $2.2 million in Q4 2024, and up 156.68% quarter-over-quarter from -$247000.0 in Q3 2025.

Analysis

GH Research (GHRS) Other Non Operating Income (2020 - 2026) Analysis & Trends

GH Research's Other Non Operating Income history runs 5 years deep, the most recent figure standing at $140000.0 for Q4 2025.

  • In Q4 2025, Other Non Operating Income fell 93.6% year-over-year to $140000.0; the TTM figure through Dec 2025 stood at $1.8 million (down 17.66% YoY), while the FY2025 annual figure was $1.8 million, down 17.66% from the prior year.
  • Other Non Operating Income for Q4 2025 stood at $140000.0, up from -$247000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $7.1 million in Q2 2022, with the low at -$7.4 million in Q4 2022.
  • The 5-year median for Other Non Operating Income is $937500.0 (2021), against an average of $1.2 million.
  • Peak annual rise in Other Non Operating Income reached 25022.22% in 2022, while the deepest fall reached 393.04% in 2022.
  • GH Research's Other Non Operating Income stood at $2.5 million in 2021, then tumbled by 393.04% to -$7.4 million in 2022, then soared by 172.88% to $5.4 million in 2023, then sank by 59.52% to $2.2 million in 2024, then plunged by 93.6% to $140000.0 in 2025.
  • Business Quant data shows GHRS's Other Non Operating Income at $140000.0 in Q4 2025, -$247000.0 in Q3 2025, and $2.5 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 GH Research 1.71 Bn 1.35 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.31 Mn
Mar 31, 2026 -2.33 Mn
Dec 31, 2025 2.58 Mn
Sep 30, 2025 2.55 Mn
Jun 30, 2025 5.42 Mn
Mar 31, 2025 -642,000.00
Dec 31, 2024 4.14 Mn
Sep 30, 2024 507,000.00
Jun 30, 2024 2.84 Mn
Mar 31, 2024 3.86 Mn
Dec 31, 2023 -113,000.00
Sep 30, 2023 4.07 Mn
Jun 30, 2023 2.20 Mn
Mar 31, 2023 -518,000.00
Dec 31, 2022 -7.41 Mn
Sep 30, 2022 6.19 Mn
Jun 30, 2022 7.08 Mn
Mar 31, 2022 2.24 Mn
Dec 31, 2021 2.52 Mn
Sep 30, 2021 2.83 Mn